INS and alopecia: Treatment with tirzepatide has demonstrated significant and rapid improvement in glycemic control through concurrent improvements in beta-cell function and insulin sensitivity. It is possible that by minimizing insulin resistance, tirzepatide avoids the pathogenic miniaturization of the hair follicle responsible for alopecia.